Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
Vivozon Pharmaceutical Co Ltd
Research & Development
Vivozon Pharmaceutical Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
V
|
Vivozon Pharmaceutical Co Ltd
KOSDAQ:082800
|
Research & Development
-₩3.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-57%
|
CAGR 10-Years
-23%
|
|
|
SK Hynix Inc
KRX:000660
|
Research & Development
-₩5.9T
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-14%
|
|
|
DB HiTek Co Ltd
KRX:000990
|
Research & Development
-₩97.3B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-8%
|
|
|
H
|
Hana Micron Inc
KOSDAQ:067310
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
L
|
Leeno Industrial Inc
KOSDAQ:058470
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
F
|
Fadu Inc
KOSDAQ:440110
|
Research & Development
-₩66.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vivozon Pharmaceutical Co Ltd
Glance View
Vivozon Pharmaceutical Co., Ltd. engages in the manufacture and sale of compound semiconductors. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2005-11-18. The firm operates its business through three segments. The Pharmaceutical Business segment is engaged in the manufacture and sale of finished medicines such as external skin preparations, antipyretic analgesic, anti-inflammatory drugs and antidiabetic drugs. The Optical Business segment is engaged in the manufacture and sale of finished products and lighting module sets such as general lighting and automotive lighting using light emitting diode (LED) light sources. The Cosmetics Business segment is engaged in the manufacture and sale of cosmetics and cosmetic ingredients.
See Also
What is Vivozon Pharmaceutical Co Ltd's Research & Development?
Research & Development
-3.4B
KRW
Based on the financial report for Sep 30, 2025, Vivozon Pharmaceutical Co Ltd's Research & Development amounts to -3.4B KRW.
What is Vivozon Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-23%
Over the last year, the Research & Development growth was 3%. The average annual Research & Development growth rates for Vivozon Pharmaceutical Co Ltd have been -11% over the past three years , -57% over the past five years , and -23% over the past ten years .
